What's new

[Cyprus Times] "Green" EMA on another adapted COVID-19 vaccine for Omicron. "Important step" says Kyriakidou

epitroposkiriakidoufh.jpg

"Green" EMA on another adapted COVID-19 vaccine for Omicron "Important step" says Kyriakidou

Positive opinion for approval of two more BioNTech-Pfizer (Comirnaty) modified booster vaccines for the treatment of BA.4 and BA.5 subvariants of the Omicron variant of the SARS-CoV-2 virus, which causes COVID-19, has been given a decision by the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA).

"This is another important step to support Member States' autumn and winter vaccination efforts," Health Commissioner Stella Kyriakidou said in a Twitter post, adding that the Commission's approval for the vaccines' marketing is expected soon.

Recall that the EMA gave the green light on 1 September 2022 for the approval of modified BA.1 sub variant vaccines of Omicron, produced by BioNTech-Pfizer (Comirnaty) and Moderna (Spikevax).

The European Centre for Disease Prevention and Control (ECDC) and the EMA have published recommendations on the use of the modified vaccines in Member States' vaccination campaigns in view of the autumn and winter season.

In particular, ECDC and EMA recommend the administration of modified vaccines as a priority for people over 60 years of age, immunocompromised individuals, vulnerable individuals with underlying diseases and pregnant women.

Source: CNA


Contents of this article including associated images are belongs Cyprus Times
Views & opinions expressed are those of the author and/or Cyprus Times

Source
 
Back
Top